成大生物：关于以集中竞价交易方式回购公司股份的进展公告

Core Viewpoint - Chengda Biological announced that it did not implement any share repurchase in January 2026, with a total of 384,899 shares repurchased by January 31, 2026, representing approximately 0.092% of the company's total share capital [1] Summary by Category - Share Repurchase Activity - The company has repurchased a total of 384,899 shares through the Shanghai Stock Exchange trading system via centralized bidding [1] - The repurchased shares account for about 0.092% of the company's total share capital as of January 31, 2026 [1]